CONTRACT FOR CARE · RIGHTS, CONSENT & GOVERNMENT POWER
Our Legal Case
A patient’s need for medicine should not become the pressure used to obtain a criminal admission. Examine compulsory disclosures, penalties for silence, coerced rights waivers, and the circumstances behind the signature.
Use this state record to trace the legal requirement, then compare it with the terms an office adds. The full work explains the constitutional case, consent analysis, evidence needed, and protections to demand.
Apply the constitutional and consent review to this record
- Government responsibility: Which law, binding rule, agency instruction, or public-provider policy requires the particular disclosure or consequence? Separate it from provider-added terms.
- Potential criminal admission: Identify the exact spoken answer, written history, certification, or explanation and the real criminal risk it creates.
- Penalty for silence: Record what happens if the patient invokes the privilege or refuses a rights waiver, including denial, discharge, or interruption of treatment.
- Consent and pressure: Preserve the circumstances of signing, severity of pain, accessible alternatives, and whether the patient could honestly accept the prospective obligations.
- Criminal-use protection: Identify legally sufficient immunity and limits on use of both the answer and evidence derived from it. A privacy assurance is a separate protection.
Read the precedents, evidence framework, clause review, and remedies and reform demands. The work develops a proposed constitutional challenge; applying it to a particular condition requires its facts and legal authority.
Maryland · Source record
Which layer requires the condition?
Maryland prescribing law, prescription-monitoring law, insurance authorization and office policy are separate layers. MD-X means the specific condition was not established as a requirement by the government sources reviewed here; it is not a finding that a condition is unlawful or clinically unnecessary. Patient, payer, prescriber and setting can change the applicable rules.
MD-S · Prescribing statute
Health Occupations §1–223 directs clinically judged lowest-effective dosing, guideline-based prescribing and benefit/risk counseling. Chronic pain is among the exceptions to the quantity provision. The section itself does not set a universal signed-contract requirement or 90-MME ceiling. It is not a complete account of every professional standard.
MD-D · Prescription monitoring
Health–General §21–2A–04.2 requires the prior four months of PDMP history before initiating covered opioid/benzodiazepine treatment, review at least every 90 days during continued treatment, assessment and documentation. Exceptions include short supplies, cancer care, specified inpatient/hospice/residential settings, certain acute post-event treatment, harmful delay and access failures. Read subsections (b)–(d) for precise scope and documentation. This duty is not a criminal-background-check mandate.
MD-P · Plan-specific authorization evidence
CareFirst Community Health Plan Maryland’s published pharmacy criteria require agreement attestation and random screens before/during treatment for covered opioid prior authorizations. Listed triggers include extended-release/long-acting agents, fentanyl, methadone for pain, over-90-MME regimens and specified immediate-release durations. Special approval provisions apply to sickle-cell disease and specified care settings. These are published coverage criteria, not a universal state prescribing limit. Current fee-for-service authority and other plans require separate confirmation.
MD-X · Office-specific detail or unresolved authority
No matching mandate for the particular condition was established in the above sources. General treatment duties, another payer rule or an individualized clinical reason may still apply. Ask the practice for the exact authority rather than assuming that every clause in a government-required agreement is itself government-required.
Document version register
- Pain and Spine Specialists: 13-page packet — 2021-marked file; selected pp. 11–13 visually checked. Current public policy page reviewed separately.
- CPC: 11-page packet and five-page medication agreement — both linked by the established-patient page; replacement clauses differ. Publication order and operative version unconfirmed. Separate participation agreement also reviewed.
- Pain Management Specialists: two-page office policy — linked on forms page; undated in reviewed text.
- Clearway medication-management description and Maryland Pain & Wellness intake page — partial policy evidence, not complete agreements.
- Interventional Pain and Spine Care patient information — agreement named; text needed.
Sources accessed October 13, 2026. Document dates, filenames and indexing dates are different facts. No publication date was inferred from a search-engine timestamp. Original PDFs remain on the source organizations’ sites.
Read the Maryland Pain Atlas and existing authority inquiry · Supply a current document or correction